Navigation Links
New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility

ng the standard of care of patients at high risk for VTE and it further establishes enoxaparin as a reference treatment for VTE prophylaxis in acutely ill medical patients".

About EXCLAIM

The EXCLAIM trial is the first international, multicenter, prospective, randomized, double-blind, placebo-controlled study. It enrolled 5,105 acutely-ill patients with recent reduced mobility in 20 countries, comparing extended-duration (28 plus or minus 4 days) venous thromboembolism (VTE) prophylaxis with enoxaparin, a low-molecular-weight heparin (LMWH) with the standard regimen of enoxaparin (10 plus or minus 4 days) for the prophylaxis of VTE.

Patients recently immobilized for up to 3 days with level 1 mobility (total bed rest or sedentary patients) or with level 2 mobility (with bathroom privileges) with age > 75 years or history of VTE or diagnosis of cancer and predefined acute medical illness were randomized to received enoxaparin 40 mg subcutaneously once daily for 10 plus or minus 4 days and were then randomized to receive the same enoxaparin regimen or placebo for an additional 28 plus or minus 4 days.

The steering committee followed the Data Safety Monitoring Board (DSMB) suggestion that in addition to level 1 mobility patients to re-define the inclusion criteria by adding on level 2 mobility patients inclusion criteria : Age >75 years, or prior VTE or diagnosed cancer.

The objective of the Exclaim study was to assess the superiority of enoxaparin prophylaxis given for 28 plus or minus 4 days versus placebo, both following an initial treatment with enoxaparin for 10 plus or minus 4 days, to reduce VTE events

The primary efficacy endpoint was the incidence of asymptomatic deep-vein thrombosis (DVT) detected by routine standardized ultrasonography, symptomatic DVT, symptomatic pulmonary embolism (PE), or fatal PE during the double-blind period. Secondary efficacy endpoints include the incidence of VTE at 3 months and the incidenc
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
11. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Post Your Comments:
(Date:8/21/2014)... Aug. 21, 2014 /CNW/ - Eisai Limited is pleased to ... the first-of-its-kind comic book available in Canada ... designed specifically to educate children and their parents about epilepsy, ... affecting more than 300,000 Canadians. Eisai is guided by ... , in which the patient is central – there was ...
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)... , N.Y. and HAMBURG, Germany , ... announced it is collaborating with Deutsches Elektronen-Synchrotron ( DESY ... Germany , to speed up management and storage ... Big Data and Analytics architecture based on IBM ... per second of data at peak performance and help ...
Breaking Medicine Technology:Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3
... 15 Prometheus Laboratories Inc., a specialty pharmaceutical ... launch of three new cancer diagnostic products: ProOnc ... Dx. Each of these tests is based on ... has a long and successful history of providing ...
... Oct. 15 Aethlon Medical, Inc. (OTC Bulletin Board: ... treatment of Hepatitis-C (HCV) infected patients with the Aethlon ... & Scientific Exposition of the American Society of Nephrology ... studies and Director of Nephrology at the Fortis Hospital ...
Cached Medicine Technology:Prometheus Launches ProOnc Dx Cancer Diagnostics 2Prometheus Launches ProOnc Dx Cancer Diagnostics 3Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference 2Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference 3
(Date:8/23/2014)... Summer vacation is almost over and before we know ... shopping for school supplies and a new wardrobe might take ... students to also spend some time brushing up on bed ... thrive in heavily populated places,” said Randy Rupert, Bed Bug ... perfect settings for bed bugs to take up residence.” , ...
(Date:8/22/2014)... Skmen.com, an experienced supplier of fashionable clothes, has unveiled ... online store. Moreover, all these excellent items are available ... the international clients can obtain these cheap bohemian ... company’s professional online workers update its product line every ... latest information about its new arrivals and the current ...
(Date:8/22/2014)... Recently, UWDress.com, a leading online supplier of ... new range of empire bridesmaid dresses to its ... a summer promotion for these high quality items. All of ... to 75 percent off. , The company’s new items ... efficient assistance on its website. It is true that all ...
(Date:8/22/2014)... Lake Worth, FL (PRWEB) August 22, 2014 ... popularity of marijuana, resulting in a high level of drug ... of all ages fight against drug addiction and work to ... the highest levels of alcohol and drug addiction in history. ... "In 2012, an estimated 23.9 million Americans aged 12 or ...
(Date:8/22/2014)... Orleans, LA The LSU Health New Orleans ... Education Nursing Traineeship grant to increase access to ... underserved and under-represented groups, as well as veterans. ... US Department of Health and Human Services awarded ... serve as the grant,s project director., The Advanced ...
Breaking Medicine News(10 mins):Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Cheap Bohemian Dresses Unveiled by Experienced Supplier Skmen.com 2Health News:Discounted Empire Bridesmaid Dresses Online At UWDress.com 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2
... projected by the U.S. Census Bureau that by the year 2030, ... million in the U.S. alone, and more than one billion worldwide. ... at least one disorder of the pelvic floor in her lifetime. ... up with practitioners across the state to create the Rhode Island ...
... to loud workplace noise may affect quality of sleep in ... by Ben-Gurion University of the Negev researchers. ... the sleep quality of individuals at the same workplace, some ... Workers with hearing loss had a higher average age ...
... Jenifer Goodwin HealthDay Reporter , MONDAY, Jan. 24 ... years old become the healthiest, wealthiest and most successful adults, ... at age 3 are more likely to drop out of ... concluded. Researchers analyzed data on about 1,000 children ...
... January 2011) -- The MSD Wellcome Trust Hilleman Laboratories ... a feasibility study into how new technologies might be ... developing country needs in mind. Formulations based on ... their potential to improve product stability, ease of use, ...
... MONDAY, Jan. 24 (HealthDay News) -- For many people, ... strong as they think. In fact, spouses sometimes ... a new study suggests. "People commonly believe ... strangers. That closeness can lead people to overestimate how ...
... Genetics in Medicine , the official journal of the ... paper by Tufts University faculty calling for a moderate, ... school curricula. For 16 months, a multi-disciplinary ... education regarding personalized genomic testing at Tufts University School ...
Cached Medicine News:Health News:Women & Infants launches Rhode Island Network for Pelvic Floor Disorders 2Health News:Self-Control Could Turn Kids Into Successful Adults 2Health News:Self-Control Could Turn Kids Into Successful Adults 3Health News:MSD Wellcome Trust Hilleman Laboratories announces first project 2Health News:Close Relationships Sometimes Mask Poor Communication 2Health News:Tufts University calls for moderate approach to teaching personalized genomic testing 2
Auto Plate Washer: 96-well washing. The ELx405 Auto Washer is the most precise and reliable washer available. Many unique features lower background absorbance values and increase the signal-to-noise ...
... microplate reader for fluorescence and absorbance ... on superior performance in both detection ... luminescence measurements. Synergy HT with 4 ... 5 mm bottom probe, incubation to ...
EL301 Microwell Strip Reader is a portable, rugged, single/dual wavelength photometer designed to measure and interpret the absorbances of microwell strip assays....
... NRTL and CE certified microstrip reader. ... strip transportation. Easy to use with ... log-logit mode and other programming enhancements. ... calibration curves, regressions, & a variety ...
Medicine Products: